In vivo evaluation of integrin αvβ6-targeting peptide in NSCLC and brain metastasis
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1070967
Abstract: Introduction Integrin αvβ6, which is upregulated in malignancies and remains absent or weak in normal tissue, is a promising target in molecular imaging therapeutics. In vivo imaging of integrin αvβ6 could therefore be valuable for… read more here.
Keywords: integrin; integrin targeting; brain; sflap3 cy5 ... See more keywords